Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
// Cen Zhang 1,* , Juan Liu 1,* , Rui Wu 1 , Yingjian Liang 1 , Meihua Lin 1 , Jia Liu 1 , Chang S. Chan 2 , Wenwei Hu 1 and Zhaohui Feng 1 1 Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers, State University of New Jersey, New Brunswick, USA 2 Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers, State University of New Jersey, New Brunswick, USA * These two authors contributed equally to this work Correspondence: Wenwei Hu, email: // Zhaohui Feng, email: // Keywords : p53, glycolysis, RRAD, hypoxia, lung cancer Received : May 17, 2014 Accepted : June 24, 2014 Published : June 26, 2014 Abstract Cancer cells display enhanced glycolysis to meet their energetic and biosynthetic demands even under normal oxygen concentrations. Recent studies have revealed that tumor suppressor p53 represses glycolysis under normoxia as a novel mechanism for tumor suppression. As the common microenvironmental stress for tumors, hypoxia drives the metabolic switch from the oxidative phosphorylation to glycolysis, which is crucial for survival and proliferation of cancer cells under hypoxia. The p53’s role and mechanism in regulating glycolysis under hypoxia is poorly understood. Here, we found that p53 represses hypoxia-stimulated glycolysis in cancer cells through RRAD, a newly-identified p53 target. RRAD expression is frequently decreased in lung cancer. Ectopic expression of RRAD greatly reduces glycolysis whereas knockdown of RRAD promotes glycolysis in lung cancer cells. Furthermore, RRAD represses glycolysis mainly through inhibition of GLUT1 translocation to the plasma membrane. Under hypoxic conditions, p53 induces RRAD, which in turn inhibits the translocation of GLUT1 and represses glycolysis in lung cancer cells. Blocking RRAD by siRNA greatly abolishes p53’s function in repressing glycolysis under hypoxia. Taken together, our results revealed an important role and mechanism of p53 in antagonizing the stimulating effect of hypoxia on glycolysis, which contributes to p53’s function in tumor suppression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744 · cited 4×
“Metabolic alterations are a hallmark of cancer cells [1-3].”
BackgroundInfluentialBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · cited 1×
“In response to stress, p53 regulates the transcription of its target genes and initiates various cellular responses, including cell cycle arrest, apoptosis and senescence, to prevent tumorigenesis [5-8].”
BackgroundThe M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“Recent studies strongly suggest that the enhanced aerobic glycolysis can exert fundamental effects on tumor cell proliferation and survival [2-4].”
BackgroundTIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 8×
“The glycolytic rate in cells was measured by monitoring the conversion of 5-3H-glucose to (3)H2O as previously described [14, 32].”
BackgroundMethodInfluentialThe first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967 · cited 1×
“In response to stress, p53 regulates the transcription of its target genes and initiates various cellular responses, including cell cycle arrest, apoptosis and senescence, to prevent tumorigenesis [5-8].”
Backgroundp53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650 · cited 7×
“Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E and Vousden KH. TIGAR, a p53inducible regulator of glycolysis and apoptosis.”
BackgroundInfluentialKruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
Macheda, M. L., Rogers, S., & Best, J. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20166 · Cited by 1,229
Vousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959 · cited 3×
“Recent studies have revealed a new function of p53 in negative regulation of aerobic glycolysis in cancer cells under normoxic conditions, which contributes greatly to the role of p53 in tumor suppression [9-11].”
BackgroundGlutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A., & Feng, Z. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001006107 · Cited by 862
Self-citation
Research works printed but not linked: 28
- Warburg, 1956, On the origin of cancer cells, Science, 123, 309, 10.1126/science.123.3191.309 · DOI · Paper page
- Vousden, 2010, p53 regulation of metabolic pathways, Cold Spring Harb Perspect Biol, 2, a001040
- Feng, 2006, The P53 pathway: what questions remain to be explored?, Cell Death Differ, 13, 1027, 10.1038/sj.cdd.4401910 · DOI · Paper page
- Levine, 2010, The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein, Trends in cell biology, 20, 427, 10.1016/j.tcb.2010.03.004 · DOI · Paper page
- Gu, 2006, p53 aerobics: the major tumor suppressor fuels your workout, Cell Metab, 4, 1, 10.1016/j.cmet.2006.06.004 · DOI
- Gillies, 2004, Why do cancers have high aerobic glycolysis?, Nature reviews Cancer, 4, 891, 10.1038/nrc1478 · DOI · Paper page
- Dang, 2007, Effects of hypoxia on tumor metabolism, Cancer Metastasis Rev, 26, 291, 10.1007/s10555-007-9060-4 · DOI
- Vasseur, 2013, Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma, Proc Natl Acad Sci U S A, 110, 3919, 10.1073/pnas.1219555110 · DOI · Paper page
- Kahn, 1993, Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans, Science, 262, 1441, 10.1126/science.8248782 · DOI · Paper page
- Kahn, 1996, Overexpression of Rad inhibits glucose uptake in cultured muscle and fat cells, The Journal of biological chemistry, 271, 23111, 10.1074/jbc.271.38.23111 · DOI · Paper page
- Chou, 2011, Rad is a p53 direct transcriptional target that inhibits cell migration and is frequently silenced in lung carcinoma cells, J Mol Med (Berl), 89, 481, 10.1007/s00109-010-0717-z · DOI
- Gazdar, 2007, Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers, Ann Surg Oncol, 14, 1397, 10.1245/s10434-006-9089-6 · doi:10.1245/s10434-006-9089-6
- Holman, 1994, Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin, Biochem J, 300, 631
- Ebina, 2000, Activation of G-protein coupled fMLP or PAF receptor directly triggers glucose transporter type 1 (GLUT1) translocation in Chinese hamster ovary (CHO) cells stably expressing fMLP or PAF receptor, J Med Invest, 47, 19
- Cagle, 1997, Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival, Cancer, 80, 1046, 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7 · DOI · Paper page
- Sakuma, 2010, Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer, Gen Thorac Cardiovasc Surg, 58, 405, 10.1007/s11748-010-0603-1 · DOI
- Prasad, 2009, Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond, Pharmacol Ther, 121, 29, 10.1016/j.pharmthera.2008.09.005 · DOI · Paper page
- Karnieli, 2004, The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression, Cancer Res, 64, 2627, 10.1158/0008-5472.CAN-03-0846 · DOI · Paper page
- Yustein, 2008, The interplay between MYC and HIF in cancer, Nat Rev Cancer, 8, 51, 10.1038/nrc2274 · DOI · Paper page
- Simon, 2007, HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation, Cancer Cell, 12, 108, 10.1016/j.ccr.2007.07.006 · DOI · Paper page
- Kahn, 1997, Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II, The Journal of biological chemistry, 272, 11832, 10.1074/jbc.272.18.11832 · DOI
- Hunziker, 2006, Nuclear sequestration of beta-subunits by Rad and Rem is controlled by 14-3-3 and calmodulin and reveals a novel mechanism for Ca2+ channel regulation, J Mol Biol, 355, 34, 10.1016/j.jmb.2005.10.013 · DOI
- Andres, 2003, Regulation of voltage-gated calcium channel activity by the Rem and Rad GTPases, Proc Natl Acad Sci U S A, 100, 14469, 10.1073/pnas.2437756100 · DOI · Paper page
- Zhu, 2011, Rad GTPase inhibits cardiac fibrosis through connective tissue growth factor, Cardiovascular research, 91, 90, 10.1093/cvr/cvr068 · DOI
- Klip, 1991, Differential regulation of the GLUT-1 and GLUT-4 glucose transport systems by glucose and insulin in L6 muscle cells in culture, The Journal of biological chemistry, 266, 2615, 10.1016/S0021-9258(18)52289-4 · DOI · Paper page
- Cushman, 1983, Insulin-stimulated translocation of glucose transporters in the isolated rat adipose cells: characterization of subcellular fractions, Biochim Biophys Acta, 763, 393, 10.1016/0167-4889(83)90101-5 · DOI · Paper page
- Giorgino, 2004, Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane, Diabetes, 53, 41, 10.2337/diabetes.53.1.41 · DOI · Paper page
- Rathmell, 2007, Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking, Molecular biology of the cell, 18, 1437, 10.1091/mbc.e06-07-0593 · DOI · Paper page
Cited by
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression
Li, Z., & Zhang, H. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2070-4 · Cited by 830
Tumor glycolysis, an essential sweet tooth of tumor cells
Paul, S., Ghosh, S., & Kumar, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.09.007 · Cited by 449
Lacroix, M., Riscal, R., Arena, G., Linares, L. K., & Le Cam, L. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.002 · Cited by 373
Zhong, X., He, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., & Li, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01358-5 · Cited by 329
Metadata
- Authors
- Zhang, C., Liu, J., Wu, R., Liang, Y., Lin, M., Liu, J., Chan, C. S., Hu, W., & Feng, Z.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2014-06-26
- Volume
- 5
- Issue
- 14
- Pages
- 5535-5546
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1556134345
- Cited by
- 97
- References
- 15
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD. https://app.cochat.ai/papers/10.18632/oncotarget.2137
- The paper
- Zhang, C., Liu, J., Wu, R., Liang, Y., Lin, M., Liu, J., Chan, C. S., Hu, W., & Feng, Z. (2014). Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD. Oncotarget. https://doi.org/10.18632/oncotarget.2137
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.